Impact of abdominal obesity on the frequency of hypertension and cardiovascular disease in Poland - Results from the IDEA study (International Day for the Evaluation of Abdominal Obesity)

Blood Pressure

Volumn 20, Issue 3, 2011, Pages 145-152

  Chrostowska, Marzena ^a   Szyndler, Anna ^a   Paczwa, Piotr ^b   Narkiewicz, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Sanofi Aventis   (Poland)

Author keywords

Abdominal obesity; cardiovascular disease; hypertension; risk factors

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POLAND; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; STROKE; WAIST CIRCUMFERENCE;

ADIPOSITY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; GENERAL PRACTITIONERS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; POLAND; PRIMARY HEALTH CARE; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; WORLD HEALTH;

EID: 79957531954     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2010.538996     Document Type: Article

References (27)

1. World Health Statistics 2009, World Health Organization, 2009, Mortality and burden of disease, WHO website: http: //www.who.int/whosis/; accessed 1 January 2010
2. Virgin SE, Schmitke JA. Metabolic syndrome. AAOHN Journal. 2003;51: 28-37
3. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).JAMA. 2001;285: 2486-2497
4. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-A new worldwide defi nition. Lancet. 2005;366: 1059-1062 (Pubitemid 41338752)
5. Wyrzykowski B, Zdrojewski T, Bandosz P. Metabolic syndrome in Poland. Kardiol Pol. 2005;62 Suppl 2: 30-35
6. Chrostowska M., Szczech R., Narkiewicz K. Antihypertensive therapy in the obese hypertensive patient. Curr Opin Nephrol Hypertens. 2006;15: 487-492
7. Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr. 2008;87: 1212-1218 (Pubitemid 351679760)
8. Freemantle N, Holmes J, Hockey A, Kumar S. How strong is the association between abdominal obesity and the incidence of type 2 diabetes? Int J Clin Pract. 2008;62: 1391-1396
9. Francesco Branca HNTL. The challenge of obesity in the WHO European Region and the strategies for response. www. euro.int./document/E90711pdf; 2007
10. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. on behalf of the INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: A case-control study. Lancet. 2005;366: 1640-1649 (Pubitemid 41552419)
11. Yusuf S Hawken S, Ounpuu S. Effects of potentially modifi - able risk factors associated with myocardial infarction in 52 countries, the INTERHEART study: Case control study. Lancet. 2004;364: 937-952 (Pubitemid 39208455)
12. World Health Organization. Obesity: Preventing and managing the global epidemic-Report of a WHO consultation on obesity. Geneva: WHO; 1998
13. Okosun IS, Chandra KM, Boev A, Boltri JM, Choi ST, Parish DC, et al. Abdominal adiposity in U.S. adults: Prevalence and trends, 1960-2000 Prev Med. 2004;39: 197-206 (Pubitemid 38797973)
14. Seidell JC, Kahn HS, Williamson DF, Lissner L, Valdez R. Report from a Centers for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care. Am J Clin Nutr. 2001;73: 123-126 (Pubitemid 32016826)
15. National Heart, Lung, and Blood Institute's Expert Panel on the Identifi cation, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identifi cation, evaluation, and treatment of overweight and obesity in adults: Executive summary. Am J Clin Nutr. 1998;68: 899-917
16. Balkau B, Deanfi eld JE, Despres JP, Bassand JP, Fox KA, Smith SC Jr, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168 000 primary care patients in 63 countries. Circulation. 2007;116: 1942-1951 (Pubitemid 350287090)
17. Wittchen H-U, Balkau B, Massien C, Richard A, Haffner S, Despr e´ s J-P, on behalf of the IDEA Steering Committee. International Day for the Evaluation of Abdominal obesity: Rationale and design of a primary study on the prevalence of abdominal obesity and associated factors in 63 countries. Eur Heart J. 2006;8 Suppl B: B26-B33 (Pubitemid 44448528)
18. Pouliot M, Despr e´ s J, Lemieux S. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73: 460-468 (Pubitemid 24096208)
19. W ang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81: 555-563
20. Fox KAA, Despreacute; s J-P, Richard A-J, Brette S, Deanfi eld JE. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91 246 ambulant patients in 27 European countries. Eur Heart J. 2009;30: 3055-3063, published ahead of print September 23, 2009 doi: 101093/eurheartj/ehp371
21. Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring).2006;14 Suppl 5: 242S-249S.
22. Gimeno RE, Klaman LD. Adipose tissue as an active endocrine organ: Recent advances. Curr Opin Pharmacol. 2005;5: 122-128 (Pubitemid 40378741)
23. Calabro P, Yeh ET. Obesity, infl ammation, and vascular disease: The role of the adipose tissue as an endocrine organ. Subcell Biochem. 2007;42: 63-91
24. Kobayashi K. Adipokines: Therapeutic targets for metabolic syndrome. Curr Drug Targets. 2005;6: 525-529 (Pubitemid 40916277)
25. Zdrojewski T, Szpakowski P, Bandosz P, Pajak A, Wiecek A, Krupa-Wojciechowska B, et al. Arterial hypertension in Poland in 2002 J Human Hypertens. 2004;18: 557-562 (Pubitemid 39173532)
26. Zdrojewski T., Bandosz P., Szpakowski P. et al, Rozpowszechnienie g l o´ wnych czynnik o´ w ryzyka chor o´ b uk l adu sercowonaczyniowego w Polsce, wyniki badania Natpol Plus. Kardiologia Polska. 2004;61 Supp IV.
27. The World Health Report. Reducing risks, promoting healthy life. WHO: Geneva; 2002